Danielle Marcotulli
Hematology & Oncology · Hackensack, NJNPI 1407220114
Payments from drug & device makers
Across 170 payments — averaging $134.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$9K
- Pfizer$3K
- Novartis$2K
- Astellas Pharma US Inc$2K
- Geron Corporation$2K
- Blueprint Medicines Corporation$1K
- plus $3K from 26 others
What the payments were for
- Consulting fees$3,83017%
- Speaking & faculty fees$12,98657%
- Travel & lodging$2,54611%
- Food & beverage$3,15214%
- Education$2841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $8,734 |
| Pfizer | 3 | $3,012 |
| Novartis | 14 | $2,436 |
| Astellas Pharma US Inc | 9 | $2,147 |
| Geron Corporation | 10 | $2,036 |
| Blueprint Medicines Corporation | 16 | $1,285 |
| CTI Biopharma Corp. | 11 | $1,039 |
| Taiho Oncology, Inc. | 11 | $389 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $220 |
| Incyte Corporation | 6 | $189 |
| GSK | 4 | $178 |
| Stemline Therapeutics Inc. | 2 | $131 |
| Bristol Myers Squibb | 7 | $116 |
| Seagen Inc. | 1 | $100 |
| Daiichi Sankyo Inc. | 6 | $100 |
| Pharmaessentia USA Corporation | 5 | $80 |
| Jazz Pharmaceuticals Inc. | 5 | $76 |
| Sobi, Inc | 4 | $71 |
| Autolus Inc | 4 | $70 |
| Sanofi | 4 | $69 |
| Adaptive Biotechnologies Corporation | 3 | $51 |
| AstraZeneca | 3 | $46 |
| Amgen | 2 | $45 |
| Agios Pharmaceuticals, Inc. | 2 | $36 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $28 |
| Rigel Pharmaceuticals, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $17 |
| Beone Medicines USA, Inc. | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Bard Peripheral Vascular, Inc. | 1 | $15 |
| Immunocore Limited | 1 | $14 |
| Syndax Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,798 in reported general payments places this provider in the 65th percentile of 362 hematology & oncology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OjjaaraMomelotinib Dihydrochloride | 11 | $311,244 |
| BosulifBosutinib | 22 | $271,214 |
| JakafiRuxolitinib Phosphate | 17 | $192,494 |
| VenclextaVenetoclax | 18 | $123,459 |
| Hydroxyurea | 18 | $392 |
| Acyclovir | 13 | $131 |
| Ondansetron Hcl | 15 | $53 |
| Pantoprazole Sodium | 11 | $39 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKOjjaara | $178 | $311,24411 claims |
| PfizerBosulif | $3,012 | $271,21422 claims |
| Incyte CorporationJakafi | $189 | $192,49417 claims |
| AbbVieVenclexta | $8,734 | $123,45918 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 362 hematology & oncology providers in New Jersey.
Other hematology & oncology in Hackensack
- Bruno FangEast Brunswick$8.5M
- Charles FarberMorristown$4.6M
- Rajat BannerjiNew Brunswick$3.3M
- Eleonora TeplinskyParamus$2.6M
- Mohamad CherryMorristown$1.9M
- Evan NaylorManahawkin$1.3M
- James OrsiniBelleville$1.3M
- Eli KirshnerWestwood$1.2M
- Linda DanieuLivingston$1.2M
- Steven PapishMorristown$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.